Banerjee Subhashis 4

What Happened
Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics (ARTV), reported a sale of 7,037 shares on 2026-05-19. The transaction generated gross proceeds of approximately $63,386. The weighted average sale price was $9.0076, with individual trade prices ranging from $8.7404 to $9.0104. According to the filing, these sales were automatic sell-to-cover transactions to satisfy tax withholding obligations tied to the vesting/release of restricted stock units, not discretionary open-market selling.

Key Details

• Transaction date: 2026-05-19
• Transaction type/code: Sale (S) — reported as open market or private sale; described in footnote as sell-to-cover for tax withholding
• Shares sold: 7,037
• Weighted average sale price: $9.0076; price range: $8.7404–$9.0104
• Gross proceeds: ~$63,386
• Shares owned after transaction: Not disclosed in the provided filing
• Footnotes: F1 — sale was automatic to cover tax withholding for vested RSUs; F2 — weighted average and price range provided; full per-price breakdown available upon request to SEC/issuer/holders
• Filing timeliness: Report filed same day as the transaction (timely)

Context
Sell-to-cover transactions are routine administrative sales to satisfy tax withholding when restricted stock units vest; they do not necessarily indicate the insider's view of the company. This was not a purchase or an exercise followed by a sale; it was a tax-withholding sale tied to compensation.